Previous close | 180.35 |
Open | 182.59 |
Bid | 184.50 x 800 |
Ask | 0.00 x 1000 |
Day's range | 181.70 - 184.83 |
52-week range | 132.24 - 243.52 |
Volume | |
Avg. volume | 1,062,117 |
Market cap | 27.097B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 30.50 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.92 (1.04%) |
Ex-dividend date | 07 Feb 2024 |
1y target est | N/A |
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beyond analysts' top -and-bottom-line estimates for ResMed (RMD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.